Time | Topics | Speaker/s |
11:00
-
11:05
|
Traumatic Optic Neuropathy Treatment Trial (TONTT); A Prospective Multicenter Semi-experimental Trial
|
Mohsen Bahmani Kashkouli, MD
|
11:08
-
11:13
|
A Novel One-Stage Obstruction-Based Endoscopic Approach to Congenital Nasolacrimal Duct Obstruction
|
Mohsen Bahmani Kashkouli, MD
|
11:16
-
11:21
|
Late Outcomes of Gold Weight and Platinum Chain for Upper Eyelid Loading
|
Raman Malhotra, MD
|
11:24
-
11:29
|
Effect of Smoking on Retrobulbar Blood Flow in Thyroid Eye Disease
|
Mansoreh Jamshidian Tehrani, MD
|
11:32
-
11:37
|
Pulled Versus Pushed Monocanalicular Silicone Intubation in Adults With Partial Nasolacrimal Duct Obstruction
|
Mansoreh Jamshidian Tehrani, MD
|
11:40
-
11:45
|
Dry Eye Syndrome in Iranian Patients With Thyroid Eye Disease
|
Hossein Aghaei, MD
|
11:48
-
11:53
|
The Effect of Implant Choice on Success Rates and Complication Rates in Frontalis Suspension Procedures
|
Michael A. Burnstine, MD
|
11:56
-
12:01
|
Meibomian Gland Inversion: A Clinical Entity Associated With Meibomian Gland Dysfunction
|
Raman Malhotra, MD
|
12:04
-
12:09
|
Lateral Rectus Muscle Recession and Palpebral Fissure Height: To Do or not to Do Intermuscular Septum Dissection?
|
Hamidreza Jahanbani Ardakani, MD
|
12:12
-
12:17
|
Ptosis Correction Surgeries for the Patients With Chronic Progressive External Ophthalmoplegia
|
Mohammad Eshaghi, MD
|
12:20
-
12:25
|
Prevalence and Factors Affecting Congenital Nasolacrimal Duct Obstruction( CNLDO) in the Neonates Born in Mobini Hospital in Sabzevar, Iran (1394)
|
Ebrahim Shirzadeh, MD
|
12:26
-
12:30
|
Questions and Answers
|
|